摘要
目的分析黄连药效组分盐酸药根碱-盐酸表小檗碱-盐酸黄连碱-盐酸巴马汀-盐酸小檗碱在清脏腑热方剂和药对中的含量及变化,为建立与临床疗效相对应的质量标准提供依据。方法采用RP-HPLC测定。结果治疗胃火牙痛者的药效组分为(0.334 4±0.03)-(0.720 5±0.07)-(1.169 6±0.06)-(1.089 7±0.23)-(4.065 3±0.37)mg·g-1;治疗协热下利、表证未解者的药效组分为(0.45±0.01)-(1.710 7±0.31)-(3.578 4±0.05)-(1.494 3±0.14)-(9.572 1±1.25)mg·g-1;治疗湿热痢疾、赤白相间者的药效组分为(0.224 2±0.02)-(0.827 4±0.23)-(1.400 1±0.16)-(0.923 2±0.04)-(2.542 9±0.19)mg·g-1。结论黄连片在复方中如果功能相同,配伍不同饮片后,药效组分变得不同,对应治疗的临床疾病也不相同。
Objective The active components alignment(ACA) of alkaloids of Coptis chinesis Franch was Jatrorrhizine hydrochloride-Epiberberine chloride-Coptisine hydrochloride-Palmatine chloride-Berberine hydrochloride.To determine the content of ACA in Visceral-heat-clearing Formula and Herb pairs.To study varying pattern of ACA and provide scientific data for the establishment of evaluation methodology of quality based on effect. Methods By using RP-HPLC. Results The ACA treating stomach-fire and toothache was(0.334 4 ± 0.03)-(0.720 5 ± 0.07)-(1.169 6 ± 0.06)-(1.089 7 ± 0.23)-(4.065 3 ± 0.37)mg·g^-1.The ACA treating diarrhea was(0.45 ± 0.01)-(1.710 7 ± 0.31)-(3.578 4 ± 0.05)-(1.494 3 ± 0.14)-(9.572 1 ± 1.25)mg·g^-1. The ACA treating dysentery was(0.224 2 ± 0.02)-(0.827 4 ± 0.23)-(1.400 1 ± 0.16)-(0.923 2 ± 0.04)-(2.542 9 ± 0.19)mg·g^-1. Conclusion The proportion of ACA in Qingwei Powder is 1 : 2.16 : 3.50 : 3.26 : 12.16; The proportion of ACA in Gegan Qinlian Decoction is 1 : 3.8 : 7.95 : 3.32 : 21.27; The proportion of ACA in Shaoyao Decoction is 1 : 3.69 : 6.24 : 4.12 : 11.34.
出处
《现代中药研究与实践》
CAS
2015年第2期62-65,共4页
Research and Practice on Chinese Medicines
关键词
清脏腑热
药效组分
黄连
Visceral-heat-clearing
ACA
Coptis chinensis Franch